C3.ai, Inc.
AI NYSE Services-Prepackaged Software Financials FY2019βFY2026
What C3.ai, Inc. does
No business description yet.
- Legal name
- C3.ai, Inc.
- Fiscal year ends
- April 30, 2026
- Latest annual report
- 10-K Β· Jun 24, 2026
- Accession Β· CIK
- 0001577526-26-000078
0001577526
Revenue and margins
C3.ai, Inc. had $250M of revenue in fiscal 2026, down 35.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$192M in fiscal 2026, β76.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
C3.ai, Inc. returned β to shareholders in fiscal 2026. The diluted share count rose 8.8%.
Balance sheet
Cash, debt and the ratios that show how comfortably C3.ai, Inc. can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $960M | $731M | $750M | $743M | $575M |
| Current ratio | 7.1x | 6.5x | 8.8x | 6.9x | 6.6x |
| Quick ratio | 7.1x | 6.5x | 8.8x | 6.9x | 6.6x |
| Total assets | $1.2B | $1.1B | $1.0B | $1.0B | $816M |
| Total liabilities | $181M | $173M | $165M | $188M | $163M |
| Shareholders' equity | $989M | $930M | $873M | $838M | $654M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 4 | 4 / 7 | 2 / 7 | 2 / 8 | 3 / 8 | 3 / 8 | 1 / 8 |
| Accruals ratio | β | β2.7% | β2.4% | β8.9% | β13.5% | β20.3% | β24.0% | β30.4% |
| Altman Z'' | β | β2.45 | 12.69 | 8.19 | 5.94 | 5.15 | 3.13 | β2.43 |
8 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $91.6M | $157M | $183M | $253M | $267M | $311M | $389M | $250M |
| Gross profit | $61.2M | $118M | $139M | $189M | $180M | $179M | $236M | $77.4M |
| Research and development | $37.3M | $64.5M | $68.9M | $151M | $211M | $201M | $226M | $229M |
| Operating income | β$36.0M | β$71.5M | β$60.3M | β$196M | β$290M | β$318M | β$324M | β$498M |
| Pretax income | β$33.1M | β$69.0M | β$55.0M | β$191M | β$268M | β$279M | β$288M | β$470M |
| Income tax | $0.3M | $0.4M | $0.7M | $0.8M | $0.7M | $0.8M | $1.0M | $0.8M |
| Net income | β$33.3M | β$69.4M | β$55.7M | β$192M | β$269M | β$280M | β$289M | β$470M |
| Diluted EPS | β | β | β | β$1.84 | β$2.45 | β$2.34 | β$2.24 | β$3.35 |
| Diluted shares | β | β | β | 0.10B | 0.11B | 0.12B | 0.13B | 0.14B |
| Cash flow | ||||||||
| Cash from operations | β$34.9M | β$61.3M | β$37.6M | β$86.5M | β$116M | β$62.4M | β$41.4M | β$190M |
| Capital expenditure | $6.8M | $2.3M | $1.6M | $3.8M | $70.5M | $25.3M | $3.0M | $1.9M |
| Free cash flow | β$41.7M | β$63.6M | β$39.2M | β$90.3M | β$186M | β$87.6M | β$44.4M | β$192M |
| Depreciation and amortization | $0.6M | $1.3M | $4.3M | $5.2M | $6.1M | $12.7M | $12.6M | $13.6M |
| Stock-based compensation | $4.3M | $8.3M | $21.7M | $113M | $217M | $216M | $231M | $264M |
| Share buybacks | β | $0.0M | $0.0M | $15.0M | $0.0M | $0.0M | β | β |
| Dividends and buybacks | β | $0.0M | $0.0M | $15.0M | $0.0M | $0.0M | β | β |
| Balance sheet | ||||||||
| Cash and short-term investments | $98.6M | $245M | $1.1B | $960M | $731M | $750M | $743M | $575M |
| Current assets | β | $281M | $1.2B | $1.1B | $889M | $904M | $904M | $708M |
| Current liabilities | β | $81.0M | $124M | $150M | $136M | $102M | $132M | $107M |
| Property and equipment, net | β | $8.7M | $6.1M | $14.5M | $84.6M | $88.6M | $79.3M | $66.9M |
| Goodwill | β | $0.6M | $0.6M | $0.6M | $0.6M | $0.6M | $0.6M | $0.6M |
| Total assets | β | $305M | $1.2B | $1.2B | $1.1B | $1.0B | $1.0B | $816M |
| Total liabilities | β | $93.8M | $135M | $181M | $173M | $165M | $188M | $163M |
| Shareholders' equity | β$165M | β$183M | $1.1B | $989M | $930M | $873M | $838M | $654M |
| Margins | ||||||||
| Gross margin | 66.8% | 75.2% | 75.7% | 74.8% | 67.6% | 57.5% | 60.6% | 30.9% |
| Operating margin | β39.3% | β45.6% | β32.9% | β77.6% | β108.9% | β102.5% | β83.4% | β199.2% |
| EBITDA margin | β38.7% | β44.8% | β30.5% | β75.5% | β106.6% | β98.4% | β80.1% | β193.8% |
| Net margin | β36.4% | β44.3% | β30.4% | β76.0% | β100.8% | β90.1% | β74.2% | β187.9% |
| FCF margin | β45.5% | β40.6% | β21.4% | β35.7% | β69.8% | β28.2% | β11.4% | β76.8% |
| Returns | ||||||||
| Return on capital employed | β | β31.9% | β5.6% | β19.2% | β30.0% | β34.0% | β36.3% | β70.2% |
| Return on equity | β | β | β12.7% | β18.7% | β28.0% | β31.0% | β33.7% | β63.0% |
| Return on assets | β | β22.7% | β7.4% | β16.2% | β23.6% | β26.1% | β28.0% | β51.1% |
| Return on tangible equity | β | β | β5.3% | β19.4% | β28.9% | β32.0% | β34.5% | β72.0% |
| Growth | ||||||||
| Revenue growth | β | 71.0% | 16.9% | 38.0% | 5.6% | 16.4% | 25.3% | β35.7% |
| Share count change | β | β | β | β | 5.2% | 8.7% | 8.1% | 8.8% |
| Financial health | ||||||||
| Current ratio | β | 3.5x | 9.4x | 7.1x | 6.5x | 8.8x | 6.9x | 6.6x |
| Quick ratio | β | 3.5x | 9.4x | 7.1x | 6.5x | 8.8x | 6.9x | 6.6x |
| Capital allocation | ||||||||
| Capex / revenue | 7.4% | 1.5% | 0.9% | 1.5% | 26.4% | 8.1% | 0.8% | 0.8% |
| Stock comp / revenue | 4.7% | 5.3% | 11.9% | 44.9% | 81.2% | 69.5% | 59.4% | 105.4% |
| Quality scores | ||||||||
| Piotroski F-score | β | β | 4.0 | 2.0 | 2.0 | 3.0 | 3.0 | 1.0 |
| Altman Z'' | β | β2.5 | 12.7 | 8.2 | 5.9 | 5.1 | 3.1 | β2.4 |
| Accruals ratio | β | β2.7% | β2.4% | β8.9% | β13.5% | β20.3% | β24.0% | β30.4% |
Source: SEC EDGAR XBRL filings (CIK 0001577526). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.